SPHINGO- AND PHOSPHO-LIPIDS METABOLISM IMPAIRMENT AS A POTENTIAL THERAPEUTIC TARGET IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) NEUROPATHY

被引:0
|
作者
Capodivento, G. [1 ,2 ]
Visigalli, D. [1 ,2 ]
Basit, A. [3 ]
Pastore, V. P. [4 ]
Armirotti, A. [3 ]
Schenone, A. [1 ,2 ]
Nobbio, L. [1 ,2 ]
机构
[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy
[2] Univ Genoa, CEBR, Genoa, Italy
[3] Ist Italiano Tecnol IIT, Drug Discovery & Dev Dept, Genoa, Italy
[4] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn DIBRIS, Genoa, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S5 / S5
页数:1
相关论文
共 50 条
  • [1] SENSITIVE OUTCOME MEASURES IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) NEUROPATHY
    Mori, L.
    Francini, L.
    Prada, V
    Signori, A.
    Accogli, S.
    Bragadin, Monti M.
    Bolla, S.
    Pareyson, D.
    Padua, L.
    Fabrizi, G.
    Schenone, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 : S21 - S21
  • [2] MITOCHONDRIAL DYSFUNCTION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) NEUROPATHY
    Nobbio, L.
    Fiorese, F.
    Ravera, S.
    Benvenuto, F.
    Panfoli, I
    Schenone, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 109 - 110
  • [3] MITOCHONDRIAL DYSFUNCTION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) NEUROPATHY
    Fiorese, F.
    Ravera, S.
    Benvenuto, F.
    Panfoli, I
    Schenone, A.
    Nobbio, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 14 - 14
  • [4] CHARCOT-MARIE-TOOTH DISEASE TYPE-1A (CMT1A) PLUS
    Simmons, M.
    Tao, F.
    Abreu, L.
    Zuchner, S.
    Li, J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 384 - 385
  • [5] IDENTIFICATION AND VALIDATION OF DISEASE MARKER IN CHARCOT-MARIE-TOOTH DISEASE 1A (CMT1A)
    Fledrich, R.
    Schlotter-Weigel, B.
    Schnizer, T.
    Stassart, R. M.
    Wichert, S.
    Hoerste, Meyer Zu G.
    Weiss, B. G.
    Haag, U.
    Walter, M. C.
    Rautenstrauss, B.
    Paulus, W.
    Nave, K-A
    Rossner, M. J.
    Sereda, M. W.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S39 - S40
  • [6] Expression of ciliary neurotrophic factor (CNTF) in Charcot-Marie-Tooth type 1A (CMT1A) disease
    Vigo, T
    Schenone, A
    Mancardi, G
    Abbruzzese, M
    Nobbio, L
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2005, 10 : 100 - 101
  • [7] TRIAL OF ASCORBIC ACID IN CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A): BASAL ASSESSMENT
    Pareyson, D.
    Schenone, A.
    Fabrizi, G. M.
    Santoro, L.
    Quattrone, A.
    Vita, G.
    Padua, L.
    Gemignani, F.
    Visioli, F.
    Laura, M.
    Reilly, M. M.
    Calabrese, D.
    Solari, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 117 - 117
  • [8] LINKAGE MAPPING OF CHARCOT MARIE TOOTH NEUROPATHY (CMT1A)
    NICHOLSON, GA
    CYTOGENETICS AND CELL GENETICS, 1991, 58 (3-4): : 2008 - 2008
  • [9] INVESTIGATION OF SENSORS TO IDENTIFY GAIT BIOMARKERS IN INDIVIDUALS WITH CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A)
    Baker, Lindsay
    Dinesh, Karthik
    Sowden, Janet
    Behrens-Spraggins, Steffen
    Charles, Julie
    Wood, Elizabeth
    Sharma, Gaurav
    Herrmann, David
    Eichinger, Katy
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S12 - S13
  • [10] P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A)
    Nobbio, L.
    Visigalli, D.
    Mannino, E.
    Pareyson, D.
    Sereda, M. W.
    Prada, V
    Mancardi, G.
    Zocchi, E.
    Bruzzone, S.
    Schenone, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 80 - 80